AMGEN

  • About Amgen
  • Science
  • Corporate Citizenship
  • Sitemap
  • Search
  • Privacy & Terms
  • Contact Us
  • Patients
  • Medical Professionals
  • Partners
  • Investors
  • Careers
  • Media
read more
  • Jul 31 / Amgen Licenses Molecule for the Treatment of Chronic...
  • Jul 30 / Amgen Issues Statement in Response to Revised ESA...
  • Jul 28 / Amgen's Second Quarter 2008 Adjusted Earnings Per...
  • Jul 25 / Amgen Announces Positive Top-Line Results for Denosumab...
Featured Links Amgen Tour of California Breakaway From Cancer
© 2000-2005 Amgen Inc. All Rights Reserved.